Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Health Care Cost | Breast Cancer Evaluation Measures

Health care costs measures for breast cancer screening1-5

In contrast with the worker productivity costs described above, health care costs are measures of the direct medical expenses of providing employee health care and preventive health programs.

Baseline  

  • Determine costs and use for health care such as outpatient visits, screening, diagnostic procedures (e.g., biopsies), one-on-one education counseling, hospitalizations, and treatment (e.g., surgery or chemotherapy) for breast cancer related illness and disability
  • Determine the health care use and costs of program participants before education and other programs are initiated and after operation of these programs

Process

  • Periodic repeats of baseline measures

Outcome

  • Assess changes in health care use and costs from baseline
  • Compare health care use and costs of program participants before education and other programs are initiated and after operation of these programs
  • Breast cancer screening is a valuable detection tool that can identify breast cancer at an early stage when treatment is more effective and less expensive. As screening rates improve, detection of breast cancers will show an early overall increase. Over the long term, the rates of detection of early stage tumors should increase while detection of tumors already in their late stages should decrease
  • Breast cancer diagnosis rates may increase in the short term due to improved screening. Changes in costs for breast cancer treatment are long term measures and may not occur for several years  
  • Decreases in breast cancer death rates may not occur for several years

References

1.  Centers for Disease Control and Prevention with the Prudential Center for Health Care Research. The manual of intervention strategies to increase mammography rates. 1997. Available from: https://www.cdc.gov/cancer/nbccedp/pdf/prumanual.pdf [PDF – 4.4MB]

2.  Campbell KP, Lanza A, Dixon R, Chattopadhyay S, Molinari N, Finch RA, editors. A Purchaser’s Guide to Clinical Preventive Services: Moving Science into Coverage. Washington, DC: National Business Group on Health; 2006. 

3.  Centers for Disease Control and Prevention. Framework for program evaluation in public health. Morbidity and Mortality Weekly Report 1999;48(No. RR-11): 1-40.

4.  Goetzel RZ, Ozminkowski RJ. Program evaluation. In: O’Donnell MP, editor. Health promotion in the workplace, 3rd edition. Albany, NY: Delmar Thomson Learning; 2002. p 116-165.

5.  Matson Koffman DM, Lanza A, Campbell KP. A Purchaser’s Guide to Clinical Preventive Services: A tool to improve health care coverage for prevention. Preventing Chronic Disease, April 2008; 5(2).

TOP